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Edited by Noboru MizushimaAbstract Here, we show that Nucleophsomin/B23 provides ly-
sine 263 as a critical binding site for ATP. Mutagenesis of lysine
263 to asparagine (K263N) disrupts B23 from ATP binding.
While B23 WT exclusively localizes to the nucleolus, the B23-
K263N is redistributed from the nucleolus to the nucleoplam.
Notably, the K263N mutant is unstable, and displayed rapid deg-
radation. Alteration of K263 induced B23 instability through in-
creased ubiquitination and proteaosomal degradation. Moreover,
mutation of K263 impedes the mitogenic eﬀect of B23 in PC12
cells. Thus, K263 is a critical site for ATP binding and required
for B23 stability, conﬁning B23 in the nucleolus.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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B23/Nucleophosmin, a phosphonucleolar protein, has been
implicated in several cellular processes, including cell prolifer-
ation [1], anti-apoptotic activity [2], cytoplasm/nuclear shut-
tling [3] and nucleolar/nucleoplasm transportation [4].
Downregulation of B23 mRNA delays the entry of cells into
mitosis [5] and overexpression of B23 induces cell cycle arrest
in normal ﬁbroblasts, whereas it accelerates the entry into S
phase in cells lacking p53, suggesting that B23 may have onco-
genic potential [6–8]. In contrast, knocking down B23 prevents
pre-ribosomal processing and causes cell death. Previous stud-
ies have suggested that B23 transport is critical for its function
in the cell. Indeed, not only does B23 shuttle nucleus/cyto-
plasm [3], but also translocates from nucleolus to nucleoplasm
during S phase [4]. The depletion of the GTP pool in culture
condition caused B23 translocation to nucleoplasm [9]. B23
translocation can also be induced by certain anti-cancer drugs
that cause growth inhibition [10]. Moreover, ATP promotes
B23 translocation from nucleolus to nucleoplasm in isolated*Corresponding author. Fax: +82 31 299 6139.
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in the C-terminus of B23 have been implicated in binding ATP
[12]. However, the ATP binding residue is unknown, and the
physiological meaning of this event is not clear as well.
In this study, we identify lysine 263 in B23 as a speciﬁc bind-
ing site of ATP. Mutation of this site into asparagines
(K263N) disrupts ATP binding and impedes B23 nucleolar res-
idency. Moreover, K263N mutation increases the instability of
B23 protein via ubiquitination and proteaosomal degradation,
aﬀecting cell proliferation. This demonstrates that K263 of
B23 is critical for eﬃcient nucleolar localization and protein
stability as well as ATP binding.2. Materials and methods
2.1. Cell cultures and reagent
PC12 cells were maintained in medium A (Dulbeccos modiﬁed Ea-
gles medium with 10% fetal bovine serum, 5% horse serum, and 100
units of penicillin–streptomycin). Stably-transfected PC12 cells with
stably inducible B23 DNA were cultured in medium B (medium A with
100 lg/ml G418, 100 lg/ml hygromycin B, and 2 lg/ml tetracycline)
and induced in medium B without 2 lg/ml tetracycline for 24 h.
Anti-Akt, anti-GST, anti-NPM, anti-HA, anti-PARP and anti-Myc
antibodies were obtained from Cell Signaling (Danvers, MA). Anti-
a-Tubulin, anti-ﬁbrillarin were acquired from Santa Cruz (Santa Cruz,
CA). Adenosine triphosphate-agarose conjugated beads (ATP-beads)
were from Fluka (Milwakuee, WI). All the chemicals not included
above were from Sigma (St. Louis, MO).
2.2. ATP binding assay
ATP binding assays were performed as previously described [13].
Brieﬂy, ATP-beads were incubated with 10 lg of puriﬁed GST-B23
protein in 400 ll binding buﬀer (40 mM HEPES, pH 7.5, 20 mM
KCl, 5 mM MgCl2, 5% glycerol) at 4 C for 2 h. The beads were
washed three times and associated protein was eluted in binding buﬀer
containing 10 mM of soluble ATP.
2.3. Immunostaining and confocal analysis
PC12 cells grown on coverslips in 6-well plates were treated with
antimycin A (5 lg/ml) for 1 h. Cells were ﬁxed with 4% paraformalde-
hyde for 15 min and permeabilized in 0.5% Triton X-100 in PBS for
15 min. Immunolocalization was determined using anti-B23 and anti-
ﬁbrillarin antibodies with the Alexa Flour 488 goat anti-mouse and
Alexa Flour 594 goat anti-rabbit ﬂuorescent dye-conjugated antibod-
ies. Cells were microscopically visualized ﬂuorescent illumination.
GFP-B23 WT and GFP-B23 K263N transfected PC12 cells were visu-
alized using a Zeiss LSM confocal ﬂuorescence microscope (Carl Zeiss,
Jena, Germany).blished by Elsevier B.V. All rights reserved.
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PC12 cells were transfected with myc-B23 WT and myc-B23 K263N
and labeled with 50 ll/ml of [35S]methionine for 2 h, and were chased
by culturing in media for the indicated times. Total cell lysates were
immunoprecipitated with anti-myc antibody and incubated with pro-
tein agarose A/G. The reaction mixtures were analyzed by autoradiog-
raphy.
2.5. Measure of ATP concentration
PC12 cells were treated with or not antimycin A (5 lg/ml) or sodium
azide(5 lM) for 12 h. Same amount of proteins were incubated with
ATP bioluminescent assay mix (Sigma). Then reaction mixture was
measured by luminotor.
2.6. Puriﬁcation of nucleoli
Nucleoli were isolated from PC12 cells as previously described (18).
In brief, puriﬁed nuclei were added to equal volumes of 0.88 M sucrose
containing 0.05 mM MgCl2. After centrifugation at 1200 · g for
10 min at 4 C, the nuclei were resuspended in 10 volumes of 0.34 M
sucrose with 0.05 mM MgCl2. Equal volumes of 0.88 M sucrose con-
taining 0.05 mM MgCl2 were centrifuged at 2000 · g for 20 min at
4 C. The supernatant containing the nucleoplasmic fraction was col-Fig. 1. Lysine 263 residue in B23 is critical docking site for ATP binding. (A
circles and B23 by squares. (B) GST-B23 deletion mutants were bound to
staining (bottom panel). B23 proteins are indicated by arrows. (C) Diagram o
circles and Myc-tag by the squares. (D) In vitro binding assay. Puriﬁed GST-
using stably tranfected PC12 cells with inducible forms of Myc-B23 WT and
and mutants proteins. Associated GST-B23 proteins with ATP-beads were elected for further analysis. The nucleolar pellet was washed twice in
0.34 M sucrose containing 0.05 mM MgCl2 and analyzed by Western
blotting.2.7. Ubiquitination assay
PC12 cells were co-transfected with myc-B23 and HA-ubiquitin.
Transiently transfected PC12 cells obtained after 24 h were treated
with or without 5 lg/ml antimycin A for 1 h and then harvested. Cells
were lysed in TBS (20 mM Tris–Cl, pH 7.2, 137 mM NaCl) containing
2% sodium dodecyl sulfate (SDS) at 95 C, 10 min and then were added
to four volumes of TBS containing 1% Triton X-100. These lysates
were sonicated for 2 min and centrifuged at 4 C. Myc-B23 in the result-
ing lysate was immunoprecipitated with 2 lg anti-myc antibody and
protein G/A agarose beads at 4 C for 4 h with rotation. The beads were
washed three times with lysis buﬀer (50 mM Tris–Cl, pH 7.4, 150 mM
NaCl, 1 mM EDTA, 0.5% Triton X100, 1.5 mM Na3VO4, 50 mM
NaF, 10 mM sodium pyrophosphate, 10 mM b-glycerolphosphate,
1 mM phenylmethylsulfonyl ﬂuoride and associated proteins were
eluted in double-strength SDS sample buﬀer at 95 C for 7 min). Eluted
proteins were subjected to immunoblotting against HA-tag to detect
ubiquitinated B23. Immunoblotting against a-tubulin and myc-tag
were a loading control.) Diagram of GST-B23 deletion constructs. GST tag is depicted by the
ATP-beads (upper panel) and presented by Coomassie Brilliant Blue
f GST or Myc-B23 lysine mutant proteins. GST tag is depicted by the
B23 mutant C fails to bind with ATP-beads. (E) ATP-pull-down assay
mutants. (F) In vitro ATP binding assay using puriﬁed GST-B23 WT
luted in 10 mM soluble ATP.
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Control vector, GFP-B23 WT and GFP-B23 K263N transfected
cells (3 · 103 cells/well) were plated onto a 96-well plate and incubated
in the medium containing 10% FBS and 5% HS without antibiotic for
6 h. The medium was then replaced 100 ll medium containing 10%
FBS, 5% HS and 1% antibiotics. 10 ll of MTT (Roche, Germany)
was added into each well, followed by incubation at 37 C for 4 h. Fi-
nally, 100 ll of solubilization solution was added. The plate was incu-
bated at 37 C overnight, and the absorption was measured at 595 nm.
2.9. Cell growth assay
The cells were transfected with pGE(control vector) and Sh-B23 for
72 h and cell growth was measured by total cell count. For rescue B23
expression, after Sh B23 transfection for 36 h, rescue of B23 expression
was performed by transfection of GFP-B23 WT and GFP-B23 K263NFig. 2. ATP binding ability of K263 is essential for B23 nucleolar retention.
detected by diﬀerential interference contrast (DIC) microscope. Arrow
Immunoﬂuorescent staining revealed GFP-B23 WT exclusively resided in
distributed entire nucleus. (C) Subcellular fractionation of Myc-B23 transfecte
NU; nucleus, NP; nucleoplasm, NO; nucleolus. (D) Naı¨ve PC12 cells were tre
was performed by using a-B23 and a-ﬁbrillarin antibody. Nuclei were stained
(E) Naı¨ve PC12 cells were treated or not with antimycin A for 12 h. Then s
Reaction mixture was measured by luminotor.and GFP. Then cell growth was measured by absorbance measurement
at 595 nm on total protein (Bradford assay).3. Results
3.1. Lysine 263 residue of B23 is a critical docking site for ATP
binding
Amino acid sequence analysis of B23 has revealed two puta-
tive ATP binding consensus sequences in the middle region
110–120 and C-terminal region 248–265 residues [12]. To
map the ATP binding site of B23 in detail, we employed a ser-
ies of recombinant GST-B23 deletion mutants to perform(A) Cellular localization of GFP-B23 WT and GFP-B23 K263N were
head indicated the nucleolus. (B) B23 subcellular distribution.
the nucleolus, co-localized with ﬁbrillarin but GFP- B23 K263N
d PC12 cells and naı¨ve PC12 cells by sucrose cushion. Cyto; cytoplasm,
ated or not with 5 lg of antimycin A. After 12 h, immunoﬂuorescence
with DAPI. Treatment with antimycin A resulted in B23 delocalization.
ame amount of cell lysates were incubated with ATP bioluminescent.
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(Fig. 1A). Most of B23 deletion mutants retained the capacity
to bind ATP. However, B23 deletion mutant that lacked the
very C-terminal 241–295 residues, the mutant that lacked
185–240 and the fragment containing 165–240, lost the ability
to bind ATP whereas the fragment containing 240–295 showed
strong binding aﬃnity with ATP, indicating that B23 likely
possesses one ATP binding site and the very C-terminus of
B23 is indispensable for ATP binding (Fig. 1B). To further as-
sess the speciﬁc amino acid residue of B23 that directly binds
to ATP, we used the selective GST-fused mutants that change
lysines into asparagines in the regions of B23 and stably trans-
fected PC12 cells with an inducible form of various Myc-B23
mutants [2] (Fig. 1C). Our in vitro binding assay revealed that
only the B23 K257, 263N mutant failed to interact with ATP
whereas B23 K223, 229N, and B23 K248, 250N mutants still
bind to ATP, which is similar to B23 WT (Fig. 1D, top).
The protein used for binding assay was veriﬁed (Fig. 1D, bot-
tom). To ensure that B23 K257, 263N mutant is responsible
for ATP binding, we performed an ATP binding assay using
stably transfected PC12 cells with an inducible form of various
Myc-B23 mutants. Compared with B23 WT, no ATP binding
activity was observed in B23 K257, 263N mutant cells. Consis-
tent with our in vitro binding assay, B23 K223, 229N, and B23
K248, 250N mutant cells showed robust interaction with ATP
as B23 WT did (Fig. 1E). To deﬁne speciﬁc ATP binding site,
we generated B23 K257N and B23 K263N mutants respec-
tively. Our in vitro binding assay revealed that B23 K263N
mutant completely lost its binding ability, whereas B23
K257N mutant still sustained the capability of ATP binding,
strongly supporting lysine 263 as a critical docking site for
ATP interaction in B23 (Fig. 1F).Fig. 3. B23 K263N is unstable than B23 WT. Half-life determination
of B23 WT and K263N protein. PC12 cells were transfected with myc-
B23 WT and myc-B23 K263N. After 24 h, cell were pulsed with [35S]
methionine for 2 h and then were chased for the indicated times. The
amount of labeled B23 protein at each time point was quantiﬁed on a
phosphorimager and normalized relative to the amount of radiolabeled
B23 present in cells following the 0 h chase. The results are plotted.3.2. K263 is essential for nucleolar localization of B23
Previous studies have shown that ATP depletion blocks B23
translocation from nucleolus to nucleoplasm [14]. To investi-
gate the biological meaning of ATP binding to B23, the subcel-
lular distribution of B23 was compared with that of K263N
mutant, which lost its binding ability for ATP by confocal
ﬂuorescence laser microscopy using GFP-tagged protein.
GFP alone diﬀused within the whole cell exclusive of the nucle-
oli (data not shown). Diﬀerential interference contrast (DIC)
imagery revealed that GFP-B23 WT exhibited extensive accu-
mulation into nucleoli, whereas GFP-B23 K263N was ob-
served throughout the entire nucleus (Fig. 2A). Moreover,
staining with anti-ﬁbrillarin, a speciﬁc nucleolar marker pro-
tein, co-localized with GFP-B23 WT, providing evidence of
B23 nucleolar localization. However, K263N mutant showed
only partial co-localization with ﬁbrillarin and complete over-
lap with 4 0-6-diamidino-2-phenylindole (DAPI) staining, indi-
cating that this mutant protein does not localize eﬃciently to
nucleoli and is distributed the entire nucleus (Fig. 2B). To con-
ﬁrm the subnuclear distribution of B23 WT and B23 K263N,
PC12 cells were subfractionated and underwent immunoblot-
ting with anti-Myc and anti-B23 antibodies. Consistent with
our microscopic observations, B23 WT exclusively localized
to the nucleolar fraction, while the K263N mutant was evident
in both the nucleoplasmic and cytoplasmic region, being
slightly more abundant in the nucleolar region. Endogenous
B23 in PC12 cells was detected in the nucleoli region whereas
small amounts of B23 were present in the nucleoplasm(Fig. 2C). These results suggest that B23 WT is predominantly
located in the nucleolus. However, K263N mutant failed to
localize in the nucleolus as eﬃcient as WT leading to its redis-
tribution from the nucleolus. To further investigate the eﬀect
of ATP on nucleolar localization of B23, we evaluated that
the deﬁciency of cellular ATP contents by antimycin A.
Myc-B23 WT cells were treated with antimycin A in a several
doses (0, 1, 2.5, and 5 lg/ml) for 1 h. Endogenous B23 was lo-
cated mostly in the nucleolus, where ﬁbrillarin speciﬁcally ex-
pressed (Fig. 2D, upper panels). Antimycin A elicited
increased nucleoplasmic staining of B23 a dose dependent
manner (data not shown). Notably, 2.5 lg/ml of antimycin A
treatment lead to B23 delocalization from nucleolus is compa-
rable to GFP-B23 K263N (Fig. 2D, bottom panels), indicating
nucleolar localization of B23 requires ATP binding. 2.5 lg/ml
of antimycin A treatment decreased more than 50% of ATP
from in Myc-B23 WT cells. We observed similar result with an-
other ATP synthesis inhibitor, sodium azaid (data not shown).
3.3. Alteration of K263 impedes B23 stability via ubiquitination
and proteaosomal degradation
No protein degradation has been found in the nucleolus [15]
and B23 is a stable protein with a half life greater than 24 h
[16]. With the ﬁnding that ATP binding mutant, B23 K263N
delocalized from the nucleolus, we wondered whether B23 sub-
nuclear localization regulated B23 protein stability. To evalu-
ate the eﬀect of nucleolar localization of B23, we determined
the half-life of B23-WT and the B23 K263N. A pulse-chase
experiment revealed the stability of the B23-WT protein,
whose half-life exceeded 24 h (Fig. 3). In contrast, the B23
K263N mutant that was incapable of binding ATP, exhibited
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degradation. Thus, one of probable reasons for the increased
instability of B23 could be the alteration of K263 with its
nucleoplasmic localization.
To search for the possible mechanism of B23 degradation
via mutation of K263, we tested whether disruption of B23
K263 could induce B23 proteasomal degradation and ubiquiti-
nation. PC12 cells were transiently transfected with Myc-
tagged B23 WT or K263N mutant and treated for 6 h with
20 lM MG-132, which is a 26 S proteasome inhibitor. The
protein level of B23 WT remained intact and barely changed
during the exposure to MG-132, whereas the protein level of
K263N was protected in response to MG-132, suggesting that
the instability of K263N at least partly mediated via proteaso-
mal degradation (Fig. 4A). The dependency of proteasomal
degradation suggested that increased instability of B23 might
be due to ubiquitination. To test this possibility, PC12 cells
were co-transfected with Myc-tagged B23 WT or K263N mu-
tant was co-transfected with HA tagged ubiquitin plasmid.
Under the normal condition, B23 WT revealed a low level ofFig. 4. Polyubiquitination and proteasomal degradation of B23 K263N. (A)
20 lMMG-132. B23 protein stability was observed by anti-B23 antibody. Imm
that a similar amount of Myc-B23 protein was expressed and a similar amou
co-transfected with Myc-B23 WT and HA-Ubiquitin, followed by no trea
cipitation with anti-Myc antibody. (C) Naı¨ve PC12 cells were pretreated w
antimycin A for 12 h with indicated concentrations. Cell lysates were probed w
assay. PC12 cells were cotransfected with HA-Ubiquitin and Myc-B23 WT
2.5 lg of antimycin A for 12 h, cell lysates were immunoprecipitated with anti
Tubulin was used for verifying same amount of protein was employed.ubiquitin conjugation, while the B23 K263N mutant exhibited
marked conjugation of ubiquitin. Furthermore, to validate
ubiquitination of B23, the WT or mutant were untreated or
were exposed to 10 lM of MG-132 for 4 h to allow accumula-
tion and detection of B23 ubiquitination. Notable polyubiqui-
tination of B23 K263N was observed even in the absence of
MG-132, and markedly increased ubiquitination in the pres-
ence of MG-132, while B23 WT displayed a low level of ubiq-
uitination that increased in the presence of MG-132 (Fig. 4B).
These results support the idea that B23 K263N is more rapidly
degraded and instable relative to B23 WT due to increased
ubiquitination and proteasomal degradation.
We extend our study to test whether disruption of B23-ATP
interaction induce B23 proteasomal degradation and ubiquiti-
nation. PC12 cells were treated with or without 20 lM MG-
132 proteasome inhibitor for 2 hours prior antimycin A treat-
ment. In cells pretreated with MG-132, B23 protein level ap-
pears slightly diminished, whereas in the absence of MG-132,
B23 protein levels were obviously decreased in a dose response
(Fig. 4C). In addition, PC12 cells were cotransfected withMyc-B23 WT or Myc-B23 K263N cells were treated with or without
unoblotting assay with anti-Myc and anti-Tubulin antibodies revealed
nt of protein was employed (middle and bottom panels). (B) Cells were
tment or treatment with 20 lM MG-132 for 4 h before immunopre-
ith or without 20 lM MG-132 for 2 h. Then, cells were treated with
ith anti-NPM and anti-Tubulin antibodies. (D) In vitro ubiquitination
or Myc-B23 K263N for 24 h. After treatment or non-treatment with
-Myc antibody and performed immunoblotting with anti-HA antibody.
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tagged ubiquitin plasmid. Under normal condition, B23 WT
revealed low level of ubiquitin conjugation, while B23
K263N mutant exhibited marked conjugation of ubiquitin.
Moreover, depletion of ATP in Myc-B23 WT transfected cells
displayed dramatically increased ubiquitination of B23. In
contrast, antimycin A treatment has only negligible eﬀect to
ubiquitination of B23 K263N mutant cells (Fig. 4D). Presum-Fig. 5. K263N mutation is defective in restoring cell growth. (A) Eﬀects of B
MTT assay. Bars indicate mean of six replicates and each value represents
control, GFP-B23 WT and GFP-B23 K263N in PC12 transient transfectants
growth. Data represent the relative cell number seen in sh-B23 transfected cel
72 h after sh-RNA transfection. An average of three independent experiments
for the K263N mutant. PC12 cells were transfected with indicated DNA for
assay) of total protein. The data are presented relative to control vector
immunoblotting with a-B23 antibody (bottom). A.U., arbitrary units. (E) De
with GFP-B23 WT, GFP-B23 K263N and pEGFP. GFP B23 expression was
are presented as in (D). At least 70% transfected cells were analyzed for ea
(Students t-test).ably, it is due to saturated ubiquitination of B23 K263N.
Hence we conclude that depletion of ATP from B23 binding
is less stable relative to normal condition due to increased
ubiquitination and proteasomal degradation.
3.4. B23K263N mutant is defective in restoring cell proliferation
Previous studies have shown that B23 protein level correlate
with cell proliferation [17]. We undertook to examine the23 WT and B23 K263N on PC12 cells proliferation were measured by
the means ± S.E. of triplicate measurements. (B) Expression of GFP
by Western blot. (C) Knocking down of B23 with sh-B23 impairs cell
ls compared with control cells transfected with pGE-vector set to 100%,
is shown. (D) Transient expression of B23 enhances cell growth but not
24 h and analyzed using absorbance 595 nm measurements (Bradford
(pEGFP) transfected cells. GFP B23 expression was conﬁrmed by
pletion of endogenous by ShB23 for 36 h was followed by transfection
conﬁrmed by immunoblotting with a-B23 antibody (bottom). The data
ch construct. These experiments were repeated three times *P < 0.01
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tions; Firstly, We determined the eﬀect of increasing GFP-
B23 WT and GFP-B23 K263N expression on PC12 cell growth
rates in vitro via MTT assay Ectopic transient expression of
GFP-B23 WT resulted in augmentation of proliferation rate,
whereas GFP-B23 K263N decreased cell proliferation of
PC12 cells (Fig. 5A). Western blot analysis showed expression
of GFP-B23 WT and GFP-B23 K263N protein in transient
transfected cells (Fig. 5B). Next, we depleted B23 by using
B23 short hairpin RNA (shRNA) in PC12 cells followed by
rescue with transient expression of GFP-B23 WT or GFP-
B23 K263N. Depletion of B23 elicited considerable impair-
ment of cell growth as measured by total cell count
(Fig. 5A). Endogenous B23 levels were substantially dimin-
ished, whereas the tubulin was not aﬀected (Fig. 5A, bottom).
On the other hands, ectopic expression of B23-WT reproduc-
ibly enhanced cell growth (Fig. 5B). Notably, introduction of
GFP-B23 WT into the cells depleted of endogenous B23 recon-
stituted cell growth, whereas GFP-B23 K263N or GFP alone
had no eﬀect (Fig. 5C), indicating that K263N mutant was
defective in promoting cell growth. The expression of GFP-
B23 and mutant were veriﬁed by ﬂuorescence microscopy.
The prominent eﬀects in K263N transfected cells raise the pos-
sibility that the mutation might cause a structural alteration,
and somehow is toxic to the cells, leading to an instable form,
thereby failing to restore its mitogenic eﬀect.4. Discussion
The C-terminus of B23 is important for interaction with nu-
cleic acids [18] and numerous lysine residues occur in the ATP
binding motif [12]. In addition, we have recently shown that
PI(3,4,5)P3 directly binds to the C-terminus of B23 and inhibits
DNA fragmentation in the nucleus. Having established the
importance of the C-terminal region of B23, we presently dem-
onstrate that the lysine 263 residue is a speciﬁc ATP binding
residue of B23, and that the alteration of this residue in B23
results in the failure of B23 WT to either re-enter the nucleolus
or to be retained in the nucleolus. Furthermore, we show that
the K263N mutant is more unstable and susceptible for pro-
tein degradation, subsequentially contributing to decreased cell
proliferation.
Independent of our study, it has been very recently demon-
strated that the lysine 263 residue is a major sumolyation site
in B23 and mutation of K263 into R abrogates its centrosomes
localization, aggregating in outside of nucleolus [19]. Indeed,
the K263N mutant of B23 was dispersed in both the nucleolus
and nucleoplasm in our study, but no aggregation was detected
(Fig. 2). B23 translocates from nucleolus to nucleoplasm dur-
ing the stationary phase of growth [4] or during exposure to
certain anti-tumor drugs [4,20]. Under conditions of lower
ATP content, B23 delocalization from the nucleolus is blocked
and newly synthesized rRNA is retained in the nuclei [14], sug-
gesting that B23 translocation occurs in a regulated manner.
However, it remains elusive how the K263 mutant of B23 (into
R or N) delocalizes from the nucleolus. It can be argued that it
is not possible to distinguish either the possibility that sumoy-
lation of B23 regulates its nucleolar localization or that ATP
binding ability of B23 is required for B23 nucleolar accumula-
tion. In addition, we cannot rule out the simple but potent pos-sibility that conformational change of B23 protein by mutation
of K263 into R or N but not sumoylation (the other sumoly-
ation site in the K230R mutant is mainly localized in the
nucleolus). ATP binding abrogates nucleolar residency of
B23, and consequently contributes to the destabilization of
B23 protein either through the failure of protecting B23 from
caspase-3 mediated cleavage [19] or due to increased protea-
some dependent degradation and ubiquitination (Fig. 5). Nev-
ertheless, K263 is a critical amino acid dictating B23 in the
nucleolus and maintaining protein stability. K263 has been
suggested to be a sumoylation site implicated in the protection
of B23 from apoptotic degradation; presently, we introduce
K263 as a critical ATP binding site that contributes to protein
stability and cell proliferation.
B23 is a stable protein and its nucleolar localization is con-
sidered as a one of the possible reasons for its stability [16,21].
Our ﬁndings that B23 mutant, K263N substantially extrude its
nucleolar localization (Fig. 3) but also decreases B23 protein
level via proteasome dependent degradation and induces B23
ubiquitination (Figs. 4 and 5) argue that K263 is crucial for
B23 protein stability. Presumably, B23 conformational change
and delocalization increases B23 instability through its in-
creased ubiquitination and proteasomal degradation.
Although it remains to be determined how ATP binding ability
maintains its nucleolar localization and protein stability on
K263, our observations indicate that under certain circum-
stances B23 binds to ATP for protein stability, conﬁning it
in the nucleolus and ultimately resulting in cell proliferation.Acknowledgement: We are thankful to Dr. Keqiang Ye for critically
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